Biobehavioral Predictors of Illness Progression in Adolescent Depression (FLASH)
Adolescence is an important time for development, and it is often a time in which mental health challenges can emerge. Our group is trying to learn more about how our bodies work and why some young people might experience mental health challenges, like depression, so we...
Age: 12 - 17 years
Gender: All
Imetelstat Combinations in Relapsed AML
IMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patients with relapsed or refractory AML. The trial will consist of a safety run-in phase (Part A) employing a 3+3 des...
Age: 18 years - 66+
Gender: All
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
The researchers will test whether cognitively enhanced transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex can reduce craving in inpatients with cocaine use disorder. Neuroimaging before and after stimulation will establish the neural co...
Age: 18 - 60 years
Gender: All
The Use of Rhythmic Light Therapy in Mild Cognitive Impairment
In this within-subjects, crossover study, participants will undergo Electroencephalogram (EEG) recordings before, during, and after each of three 1-hour sessions. All participants will experience all three conditions: (1) dual-frequency visual (10 and 40 Hz), (2) single...
Age: 55 - 80 years
Gender: All
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
This investigator-initiated, prospective study evaluates the diagnostic utility of rhPSMA-7.3 (¹⁸F) PET/CT (flotufolastat F18, marketed as POSLUMA®) in men with biopsy-proven, low-risk or favorable intermediate-risk prostate cancer managed with active surveilla...
Age: 18 years - 66+
Gender: Male
Study of Cannabidiol and Neuroimaging on Stress
Dysregulation in stress responsivity is a growing psychiatry-transdiagnostic fundamental phenomenon, with limited therapeutic strategies. With the legalization of medical and recreational cannabis, many people consume cannabidiol (CBD; a nonintoxicating cannabinoid) to ...
Age: 18 - 25 years
Gender: All
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
The purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
Age: 18 years - 66+
Gender: All
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
This is a single-center, open-label, basket phase 2b trial that will enroll Down Syndrome (DS) participants with at least one inflammatory skin condition (Atopic Dermatitis (AD) and/or Alopecia Areata (AA)). Patients will receive Abrocitinib 100 mg daily for 12 weeks. R...
Age: 12 years - 66+
Gender: All
CaOx Stone Prevention
This single-center randomized controlled trial at Mount Sinai West will enroll 80
patients undergoing percutaneous nephrolithotomy for calcium oxalate stones. Participants
will be randomized to receive either empiric therapy or selective therapy guided by
24-hour uri...
Age: 18 years - 66+
Gender: All
NIOSH R21 WTC Asthma
Aim 2: Conduct a pilot RCT of SaMBA-WTC to determine feasibility and preliminary impact
in preparation for a fully powered trial. (7M-24M) The investigators will conduct a pilot
RCT (n=58) of the SaMBA-WTC model vs. an attention control. Data will be collected on the
...
Age: 21 years - 66+
Gender: All
The Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr (SAPPHIRE): A National Study
What Is SAPPHIRE?
Inflammatory bowel disease (IBD) is a condition in which the body’s immune system reacts inappropriately and causes ongoing inflammation in the digestive tract. To manage this, many patients are often treated with immunosuppressants. Beca...
Alnuctamab for Refractory SLE (LATTE Study)
This study will assess the safety and preliminary efficacy of the bi-specific TCE, alnuctamab (known as BMS-986349, CC-93269, EM901), targeting BCMA in patients with moderate to severe SLE, refractory to standard-of-care treatments.
Age: 18 - 60 years
Gender: All
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
The purpose of this study is to test a new medicine, vepugratinib, in comparison with placebo, to see if it is safe and can help people with a bladder cancer that is advanced or has spread. Vepugratinib or placebo will be administered in combination with enfortumab vedo...
Age: 18 years - 66+
Gender: All
Assessment of Music Experiences in Navigating Depression Part 2
This study is again looking at the use of music and music therapy experiences in
navigating depression. The researchers will provide 11 sessions of music therapy and half
will be followed by recitals at the Third Street School Music Settlement where the kids
enrolled...
Age: 7 - 15 years
Gender: All
ADAPT: Approach to Dance for Autism
It is well documented that motor impairments are associated with a diagnosis of autism
spectrum disorder (ASD). Yet, appropriate therapies are scarce. Dance has been shown to
not only promote fine and gross motor skills, but also psychological well-being,
cognition, ...
Age: 6 - 12 years
Gender: All
Liver Transplant CGM
This investigator initiated study aims to describe continuous glucose monitoring (CGM)
based glycemic metrics after discharge from liver transplant and assess relationship with
glycemic metrics and liver transplant outcomes.
Age: 18 years - 66+
Gender: All
A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
This is a clinical study that has two parts. It is testing a potential new medicine called LY4170156 for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A looks at participants whose cancer no longer responds to platinum-based treatmen...
Age: 18 years - 66+
Gender: All
SAINT in Postpartum Depression (PPD)
This study is a large, multi-site clinical trial testing whether Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), a fast-acting form of repetitive transcranial magnetic stimulation (rTMS), can more effectively reduce symptoms of postpartum depression (P...
Age: 18 - 45 years
Gender: Female
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
The purpose of this study is to learn how a new medicine called PF-08052667 works when
used by itself or together with another medicine called Bacillus Calmette Guerin (BCG),
and/or a medicine called sasanlimab.
This study is for adults who have a type of bladder c...
Age: 18 years - 66+
Gender: All
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Researchers are looking for a better way to treat children who have heart failure with
left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where
the heart is unable to pump enough blood to meet the body's needs. This can lead to
symptom...
Age: 6 months - 17 years
Gender: All